Slide background
Slide background

ECHA’s response to the Global2000 report on glyphosate

ID 4519 | | Visite: 1355 | Documenti Chemicals ECHAPermalink: https://www.certifico.com/id/4519

ECHA’s response to the Global2000 report on glyphosate

Helsinki 08.08.2017

Subject: Global 2000’s report on glyphosate

Further to our initial response (published on ECHA’s website on 13 July 2017), ECHA has fully examined the Global2000 report and provides the attached more detailed response. As indicated in our previous response, this further response will also be published on ECHA’s website.

As noted previously, ECHA encourages and welcomes scientific debate and challenge – it is fundamental to our work. We therefore welcome the scientific content of the report and the challenges it poses on some of the issues raised.
However, we again most strongly refute the allegation made in the title of the Global2000 report and repeated in your response of 17 July. We have not breached the relevant regulations nor colluded with industry in arriving at the scientific opinion which is now considered by the policy makers in deciding whether to renew the approval of glyphosate as a herbicide.

ECHA notes your appreciation for the transparency and openness in welcoming observers from NGOs at the meetings of the scientific committees of ECHA and agrees that it is an important step to promote public trust.

During the plenary meeting in March 2017, ECHA’s risk assessment committee (RAC) delivered its scientific opinion which was different to what your organisation would have liked. RAC’s independent scientific experts assessed glyphosate’s hazardous properties, including carcinogenicity, against the criteria in the CLP Regulation. They considered all the scientific data in coming to their opinion, including both published scientific studies and industry sponsored scientific studies that RAC considered relevant. The Committee used a weight of evidence approach in its assessment, as required by the CLP Regulation.

RAC approached the assessment, as it has done in every other case, without any anticipation of the outcome for any of the hazard endpoints. RAC also does not set out to please any stakeholder organisation with its conclusions. There was no collective preconception of whether or not the substance was hazardous for any of the endpoints, let alone any collusion with industry, as alleged in the Global2000 report. The decision of RAC was reached by consensus, with individual
RAC members contributing their individual views on the subject as the discussion progressed.

Upon examination of all your arguments ECHA concludes that the dossier submitter (BAuA) and RAC have correctly followed all of the legal steps responsibly and with its usual scientific rigour during the process to harmonise the classification and labelling of glyphosate, respecting the CLP Regulation as well as all the OECD and ECHA’s own guidance.

Therefore, ECHA rejects all of the allegations made in the report. Furthermore, ECHA is concerned of an attempt to publicly malign the integrity of EU institutions mandated to ensure safe use of chemical substances in the EU. This is of particular concern, when the process actually provides the opportunity to submit any further data and to make any science-based observations during the process.

Finally, ECHA will at this critical decision-making stage not engage in any public discussion that could be perceived by your or other organisations as ECHA reopening its opinion. Therefore, we will consider your invitation for a public debate after the decision of the policy makers has taken place.

RAC approached the assessment without any anticipation of the outcome and adopted its Opinion on the classification of glyphosate following an independent assessment of all the scientific data.

RAC does not set out to please any stakeholder organisation with its conclusions. Any classification outcome was possible in this case. There was no collective preconception of whether or not the substance was hazardous for any of the endpoints, let alone any collusion with industry, as alleged in the Global2000 report. During the process individual RAC members formed their own views on the subject and at the end the decision of RAC was reached by consensus. RAC came to its conclusion on all the considered endpoints only after considering the overall toxicological profile based on the data in the original study reports.

RAC did not evade or hide any data and no studies were dismissed from the assessment – all important findings were discussed openly and objectively. The methodology has been appropriately applied in the CLH process as prescribed in the relevant

ECHA Guidance documents and relevant OECD guidance.

RAC has considered the evidence for classification from the animal studies, but has noted that the effects were observed inconsistently and generally only at the highest doses which in some cases were very high. Additional factors considered were the lack of evidence for mutagenicity and from epidemiology.

The Dossier Submitter as well as the experts of RAC considered all the relevant data in a weight of evidence determination conducted in accordance with the requirements in the CLP Regulation and applicable guidance, as it has done in every preceding case where the criteria cannot be applied directly to available identified information.

ECHA rejects all of the allegations made in the Global2000 report. Furthermore, ECHA is concerned of this attempt to publicly denigrate the integrity of EU institutions mandated to ensure safe use of chemical substances in the EU. It is of particular concern, when the process actually provides the opportunity to make all the points relevant to the case by legitimate means.

Fonte: ECHA

Collegati:

Glifosato non cancerogeno per ECHA

Tags: Chemicals Regolamento BPR

Articoli correlati

Ultimi archiviati Chemicals

EIGA 219 2019
Mag 11, 2019 52

Guideline for Validation of ASU and Cargo Transport Unit

Guideline for Validation of Air Separation Unit and Cargo Transport Unit Filling for Medical Oxygen and Medical Nitrogen EIGA Doc. 219/19 This publication provides the EIGA position and guidance on the manufacturing, bulk product storage, and cargo transport unit (cryogenic tankers and containers)… Leggi tutto
218 19
Mag 09, 2019 60

Medicinal VIPR Package

Medicinal VIPR Package - Lifetime Performance of Drug Delivery Device EIGA Doc. 218/19 One of the major developments on how medicinal gases are delivered to patients has been the introduction of cylinders fitted with valves that have an integrated pressure regulator. These medical gas cylinder… Leggi tutto
Decisione 2019 701
Mag 08, 2019 112

Decisione (UE) 2019/701

Decisione (UE) 2019/701 della Commissione del 5 aprile 2019 che stabilisce un glossario delle denominazioni comuni degli ingredienti da utilizzare nell’etichettatura dei prodotti cosmetici GU L 121/1 dell'08.05.2019 Entrata in vigore: 28.05.2019 Articolo 1 Il glossario delle denominazioni comuni… Leggi tutto
Prassi di riferimento 57 2019
Mag 07, 2019 77

UNI/PdR 57:2019 prodotti alimentari e bevande senza additivi

Prassi di riferimento UNI/PdR 57:2019 in materia di prodotti alimentari e bevande senza additivi L’obiettivo della prassi di riferimento è quello di definire le linee guida per prodotti alimentari e bevande e, in particolare: [alert]- fissare quali siano i requisiti ai quali gli alimenti e le… Leggi tutto
Mag 07, 2019 87

Regolamento (UE) 2019/698

Regolamento (UE) 2019/698 Regolamento (UE) 2019/698 della Commissione del 30 aprile 2019 che modifica gli allegati III e V del regolamento (CE) n. 1223/2009 del Parlamento europeo e del Consiglio sui prodotti cosmetici GU L del 07.05.2019 Entrata in vigore: 27.05.2019 ________ Articolo 1L'allegato… Leggi tutto
Mag 03, 2019 95

Rettifica del regolamento (CE) n. 1272/2008 | 03.05.2019

Rettifica del regolamento (CE) n. 1272/2008 | 03.05.2019 Rettifica del regolamento (CE) n. 1272/2008 del Parlamento europeo e del Consiglio, del 16 dicembre 2008, relativo alla classificazione, all'etichettatura e all'imballaggio delle sostanze e delle miscele che modifica e abroga le direttive… Leggi tutto
Mag 02, 2019 89

Regolamento (UE) 2019/681

Regolamento (UE) 2019/681 della Commissione del 30 aprile 2019 che modifica l'allegato II del regolamento (CE) n. 1223/2009 del Parlamento europeo e del Consiglio sui prodotti cosmetici GU L 115/5 del 02.05.2019 Entrata in vigore: 22.05.2019 Articolo 1 L'allegato II del regolamento (CE) n.… Leggi tutto
Mag 02, 2019 100

Regolamento (UE) 2019/680

Regolamento (UE) 2019/680 della Commissione del 30 aprile 2019 che modifica l'allegato VI del regolamento (CE) n. 1223/2009 del Parlamento europeo e del Consiglio sui prodotti cosmetici GU L 115/3 del 02.05.2019 Entrata in vigore: 22.05.2019 Articolo 1 L'allegato VI del regolamento (CE) n.… Leggi tutto
Linee guida OCSE e UE ai test
Mag 01, 2019 96

Linee guida OCSE e UE ai test

Linee guida OCSE e UE ai test Gli studi ai sensi delle prescrizioni in materia di informazioni sull'ecotossicità, la tossicità e le proprietà fisico-chimiche sono solitamente condotti sulla base di linee guida per le sperimentazioni, che sono state approvate dall'OCSE e dall'UE. In seguito agli… Leggi tutto
Apr 24, 2019 92

Regolamento di esecuzione (UE) 2019/637

Regolamento di esecuzione (UE) 2019/637 della Commissione del 23 aprile 2019 che approva il colecalciferolo come principio attivo destinato a essere utilizzato nei biocidi del tipo di prodotto 14 GU L109/13 del 24.04.2019 Entrata in vigore: 14.05.2019 _________ Articolo 1 Il colecalciferolo è… Leggi tutto

Più letti Chemicals

Mar 02, 2019 17234

Regolamento (CE) n. 2023/2006 (Regolamento GMP)

Regolamento (CE) n. 2023/2006 Regolamento (CE) N. 2023/2006 della Commissione del 22 dicembre 2006 sulle buone pratiche di fabbricazione dei materiali e degli oggetti destinati a venire a contatto con prodotti alimentari (Regolamento GMP - Good Manufacturing Practices) ... Il presente regolamento… Leggi tutto